Global Migraine Drugs Market (2018-2025)-GMI Research

1. Global Migraine Drugs Market (2018-2025)- GMI Research Posted by Sarah Nash September 17, 2018 in Healthcare Global Migraine Drugs Market by Drug Type (Abortive Drugs and Preventive Drugs), by Route of Administration (Oral, Injectables and Others), End User

2. (Hospital Pharmacies, Retail Pharmacies and Others), and by Geography – Opportunities & Forecast, 2018-2025 Migraine is a neurological disorder that causes severe pain in head and results in nausea, vomiting, and extreme sensitivity to light and sound. The common types of migraine are with aura and without aura that means classical migraines and common migraines. Download Sample Brochure : https://www.gmiresearch.com/sample-research- report.php?rid=132 According to migraine trust website, in 2016, migraine headaches affected about 12.0% to 14.7% of population across the globe. Migraine has been categorized by frequency and nature of attack into episodic migraine and chronic migraine as per international as well regional guidelines. Migraine is an extraordinarily prevalent neurological disease, affecting 39 million men, women and children in the US and 1 billion worldwide. As per World Health Organization (WHO) in 2016, about 50% of migraine disorders were reported, out of which, women patients were more. Rise in prevalence of migraine in the age group of 30 to 40 drives the migraine drugs market. Moreover, increase in female population and surge in awareness among patients related to prevention and treatment of migraine are the key factors that augment the growth of the market. However, side effects like fatigue, nausea, lowering of blood pressure, etc., associated with migraine drugs is a factor that hinders the market growth. Migraine disorders are among the most common disorders of the nervous system, mostly observed in adult population. Furthermore, North America holds the largest share in the migraine drugs market as it has large number of ageing population. Various notable players operating in the global migraine drugs market include Abbott Laboratories, Aegis Therapeutics, LLC, Aerial Biopharma LLC, Alder

3. Biopharmaceuticals Inc., Amgen Inc, Astellas Pharma, AstraZeneca, Johnsons and Johnsons, Eisai Co Ltd, Eli Lily & Co and others. The global migraine drugs market has been segmented on the basis of drug type, route of administration, end user and key geographies. Based on the drug type, the market comprises of abortive drugs and preventive drugs. Based on route of administration, the market is classified into Oral, Injectables and Others. Based on end user market is segmented into Hospital pharmacies, retail pharmacies and others. This research report “global migraine drugs market” provides in-depth analysis of the migraine drugs market across the globe based on drug type, route of administration, end user and major geographies for the forecast period from 2018 to 2025. The report highlights the major market drivers propelling the growth as well as challenges faced by market participants. The research report provides market size and forecast for migraine drugs market. The report also analyses the competitive landscape, major players and their strategies in 2018. The competitive landscape section of the report captures and highlights the recent developments in the market. Key questions answered in this research report: 1- At what pace is migraine drugs market growing worldwide? What will be growth trend in future? 2- What are the key drivers and restraints in the current market? What will be the impact of drivers and restraints in the future? 3- What are the regional revenue and forecast breakdowns? Which are the major regional revenue pockets for growth in the migraine drugs market? 4- What are the various application areas and how they are poised to grow? The global migraine drugs market has been segmented based on drug type, route of administration, end user and geography:

4. Global Migraine Drugs Market, by Drug Type • Abortive Drugs • Preventive Drugs Global Migraine Drugs Market, by Route of Administration • Oral • Injectables • Others (Nasal Spray, Transdermal Path, etc.) Global Migraine Drugs Market, by End User • Hospitals Pharmacies • Retail Pharmacies • Others Global Migraine Drugs Market, by Geography • North America As a part of customization o By Drug Type o By Route of Administration o By End User o United States o Canada o Mexico • Europe As a part of customization o By Drug Type o By Route of Administration o By End User o United Kingdom o Germany o Spain o Rest of Europe

5. • Asia-Pacific As a part of customization o By Drug Type o By Route of Administration o By End User o China o Japan o India o Rest of Asia-Pacific • Rest of the World As a part of customization o By Drug Type o By Route of Administration o By End User o Brazil o GCC countries o South Africa o Rest of ROW Global Migraine Drugs Market Competitive Landscape • Major Players and their Key Strategies • New Drug Launches • Mergers and Acquisitions • Collaborations, Partnerships, Agreements and Joint Ventures Leading Market Players • Abbott Laboratories • Aegis Therapeutics, LLC • Aerial Biopharma LLC • Alder Biopharmaceuticals Inc., • Amgen Inc Lucibel SA

6. • Astellas Pharma. • AstraZeneca Velmenni OÜ • Johnsons and Johnsons • Eisai Co Ltd • Eli Lily & Co Other prominent players in the market which can be profiled as a part of customization: • Teva Pharmaceutical Industries Ltd. • GlaxoSmithKline plc • Novartis AG • Merck & Co., Inc., BUY Premuim Report : https://www.gmiresearch.com/buy-research- report.php?rid=132&licence=singaluser Table of Contents (TOC) • Executive Summary • Introduction • Study Objectives • Market Definition • Market Covered • Geographical Coverage • Study Years & Currency • Market Stakeholders • Key Questions this Study will Answer •GMI Research’s Approach & Methodology • Global Migraine Drugs Market- Overview • Introduction ` • Market Segmentation

7. • Value Chain Analysis • Drivers • Restraints • Trends • Global Migraine Drugs Market Revenue Forecast till 2025 • Global Migraine Drugs Market by Drugs Type Revenue Forecast till 2025 • Abortive Drugs • Preventive Drugs • Global Migraine Drugs Market by Route of Administration Revenue Forecast till 2025 • Oral • Injectables • Others (Nasal Spray, Transdermal Path, etc.) • Global Migraine Drugs Market by End User Revenue Forecast till 2025 • Hospitals Pharmacies • Retail Pharmacies • Others • Global Migraine Drugs Market by Geography Revenue Forecast till 2025 • North America Migraine Drugs Market Revenue Forecast till 2025 • North America Migraine Drugs Market by Drug Type (Option 1: 25% customization) • Abortive Drugs • Preventive Drugs • North America Migraine Drugs Market by Route of Administration • Oral • Injectables • Others (Nasal Spray, Transdermal Path, etc.) • North America Migraine Drugs Market by End User • Hospitals

8. • Homecare Setting • Others • Europe Migraine Drugs Market Revenue Forecast till 2025 • Europe Migraine Drugs Market by Drug Type (Option 1: 25% customization) • Abortive Drugs • Preventive Drugs • Europe Migraine Drugs Market by Route of Administration • Oral • Injectables • Others (Nasal Spray, Transdermal Path, etc.) • Europe Migraine Drugs Market by End User • Hospitals • Homecare Setting • Others • Asia-Pacific Migraine Drugs Revenue Forecast till 2025 • Asia-Pacific Migraine Drugs Market by Drug Type (Option 1: 25% customization) • Abortive Drugs • Preventive Drugs • Asia- Pacific Migraine Drugs Market by Route of Administration • Oral • Injectables • Others (Nasal Spray, Transdermal Path, etc.) • Asia-Pacific Migraine Drugs Market by End User • Hospitals • Homecare Setting • Others • Rest of the World Migraine Drugs Market Revenue Forecast till 2025

9. • Rest of the World Migraine Drugs Market by Drug Type (Option 1: 25% customization) • Abortive Drugs • Preventive Drugs • Rest of the World Migraine Drugs Market by Route of Administration • Oral • Injectables • Others (Nasal Spray, Transdermal Path, etc.) • Rest of the World Migraine Drugs Market by End User • Hospitals • Homecare Setting • Others • Competitive Landscape • Industry Attractiveness • Porter 5 Analysis • Major players and their key strategies • Company Share Analysis • Company Profiles (Option 5: 25% Customization – Profiles of 5 Additional Companies of your Choice) • Abbott Laboratories • Company Overview • Financials • Recent Developments • Aegis Therapeutics • Company Overview • Financials • Recent Developments • Aerial Biopharma LLC • Company Overview

10. • Financials • Recent Developments • Alder Biopharmaceuticals Inc • Company Overview • Financials • Recent Developments • Amgen Inc • Company Overview • Financials • Recent Developments • Astellas Pharma India Private Limited • Company Overview • Financials • Recent Developments • AstraZeneca • Company Overview • Financials • Recent Developments • Johnsons and Johnsons Services Inc • Company Overview • Financials • Recent Developments • Eisai Co Ltd. • Company Overview • Financials • Recent Developments • Eli Lily & Co • Company Overview

11. • Financials • Recent Developments • About GMI Research For Sample Pages & Detailed Report Description Visit :https://www.gmiresearch.com/report/global-migraine-drugs-market- opportunities-forecast-share-trends-insights.html About US GMI Research is a market research and consulting firm which provides research- based solutions to business executives and investment professionals so that they can make right business & investment decisions faster based on real facts. We help business leaders through independent fact-based insight, ensuring their business achieve success by beating the competition. Contact – Sarah Nash Level 1, The Chase Carmanhall Road, Sandyford Industrial Estate, Dublin D18 Y3X2, Ireland U.S Office +1 860 881 2270 Europe Office +353 1 442 8820 Email: sales@gmiresearch.com